Data on HPV vaccination coverage, screening attendance, cervical cancer related burden and healthcare costs, and sexual activity when available, will be systematically collected in reference countries. The data will be transformed for model input. The cervical cancer screening model will be adjusted to these reference countries and validated using selected reference countries. A set of screening scenarios will be modelled to identify feasible and optimal scenarios for each reference country.
This task will be led by THL, Finland.